The global antidepressant market is expected to grow at a significant CAGR of 2.5% during the forecast period (2022-2028). Depression is a mental disorder marked by a lack of positive emotions, a persistent low mood, including a number of cognitive, physical, behavioral and emotional cues and symptoms. Antidepressants work by increasing the amounts of stimulating neurotransmitters, which are molecules produced by nerve cells that act as messengers in the nervous system. The global market for depression medicine is mainly driven by an increase in the incidence of depression due to an unhealthy and hectic lifestyle. According to the World Health Organization, in 2021, depression is a common disorder affecting 3.8% of the global population (280 million), with 5.0% of adults and 5.7% of people over the age of 60 suffering from depression.
An increased incidence of life-threatening disorders such as major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder and panic disorder are important reasons driving the antidepressant drug industry. The COVID-19 epidemic has caused an increase in depressive and anxiety disorders. In addition, the epidemic is increasing the demand for psychiatric care. Bereavement, isolation, loss of income and fear can all provoke or exacerbate mental problems. Many people also suffer from insomnia, psychosis, agitation and stroke after the plague. Prevalence of such disorders produces growth opportunities for the antidepressant market.
Moreover, the market is expected to evolve as the number of approvals for antidepressants increases. For example, in March 2019, Janssen Pharmaceutical, Inc. Has received approval for Spravato (esketamine) nasal spray in combination with an oral antidepressant to treat depression in people who have tried but failed to benefit from other antidepressants.
Based on the type of drug, the antidepressant segment holds the largest share in the antidepressant market. Antidepressants can help with social anxiety disorder, depression, seasonal emotional disorder, moderate chronic depression and dysthymia, among others. Antidepressants are prescribed by a number of doctors to their patients suffering from depression. According to NHS Business Services Statistics, more than 20 million antidepressants were registered between October and December 2020, an increase of 6% over those three months in 2019.
(Get a 15% discount on the purchase of this report)
Get a sample copy of the Global Depression Medicine Market at:
https://orionmarketreports.com/request-sample/?id=96400&submit=Request+Sample%0D%0A
Market coverage
• Available market number for – 2021-2028
• Base year – 2021
• Forecast period – 2022-2028
• Covered segment-
o By type of drug
o Upon request
o By distribution channel
• Covered areas-
o North America
o Europe
o Asia-Pacific
o The rest of the world
• Competitive Landscape-Eli Lilly & Co., Johnson & Johnson, Pfizer, Mark & Co. Ltd., and F. Hoffman-La Roche Ltd., among others.
Key questions addressed in the report
• What is the growth rate of the market?
• Which segment and region dominate the market in the base year?
• Which segment and region will expect the fastest growth in the market?
• How has COVID-19 affected the market?
o Deviation from the forecast before COVID-19
o The area and section most affected
• Who is the market leader?
• How do players face challenges to sustain growth?
• Where is the investment opportunity?
A full report of the global depression medicine market is available at:
https://orionmarketreports.com/global-depression-medicine-market/96400/
Global Depression Medicine Market Report by Sector
By type of drug
• Antidepressants
• Antipsychotic drugs
By application
• Severe depressive disorder
• bipolar disorder
• Postpartum depression,
• Premenstrual dysphoric disorder
• Dysthymic disorder,
By distribution channel
• Pharmacies for hospitals
• Retail pharmacies
• Online pharmacies
Global Depression Medicine Market Report by Region
North America
• United States
Canada
Europe
• United Kingdom
Germany
• Italy
• Spain
• France
• The rest of Europe
Asia Pacific
• Porcelain
India
• Japan
• Rest of Asia-Pacific
the rest of the world
• Latin America
• Middle East and Africa
About us:
Orion Market Reports (OMR) strives to provide an exclusive combination of quality and quantitative market research reports to clients around the world. Our organization helps multinational and local organizations alike to strengthen their business by providing in-depth market insights and highly reliable future market trends. Our reports cover all major aspects of the markets and provide market insights and forecast to global customers.
Communication contact:
Company Name: Orion Market Reports
Contact: Mr. Anorg Tiwari
Email: [email protected]
Contact number: +91 780-304-0404